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Comparison of CIDR to MGA in a 7-11 cosynch protocol with timed insemination
of beef heifers
Abstract
Previous research has shown that the 7-11 Cosynch protocol using melengestrol acetate (MGA) is
effective in synchronizing beef heifers. This study compared MGA and a vaginal insert containing
progesterone (CIDR) in the 7-11 Cosynch protocol on beef heifers. Replacement beef heifers (n=179) from
three herds were assigned to MGA or CIDR treatments. Beginning on day 1, heifers on the MGA treatment
were fed to consume 0.5 mg daily of MGA for 7 days. On day 7, the last day of MGA feeding, the MGA
heifers received an injection of Lutalyse (PGF). Heifers on the CIDR treatment received a CIDR on day 3;
on day 9 the CIDR was removed, and heifers received an injection of Lutalyse. On day 11, all heifers
received an injection of OvaCyst (gonadotrophin-releasing hormone; GnRH), followed by another injection
of Lutalyse® 7 days later (day 18). At 48 hours after the final Lutalyse injection, all heifers were time
inseminated and received an injection of OvaCyst. Pregnancy status was determined 33 days after
breeding by ultrasonography. No difference in pregnancy rate was observed between the CIDR (46%) and
MGA (47%) treatments.
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COMPARISON OF CIDR TO MGA IN A 7-11 COSYNCH PROTOCOL WITH
TIMED INSEMINATION OF BEEF HEIFERS
D. R. Eborn, G. E. Freneau, and D. M. Grieger

ening the calving season, and creating a more
uniform calf crop, yet many beef producers
have yet to embrace this technology. One
possible explanation is that conception rates
are not yet acceptable, given the time and cost
involved. Time could be reduced by shortening the synchronization time and by more effectively synchronizing the estrous cycle and
time of ovulation to yield greater conception
rates to a timed artificial insemination.

Summary
Previous research has shown that the 7-11
Cosynch protocol using melengestrol acetate
(MGA) is effective in synchronizing beef
heifers. This study compared MGA and a
vaginal insert containing progesterone (CIDR)
in the 7-11 Cosynch protocol on beef heifers.
Replacement beef heifers (n=179) from three
herds were assigned to MGA or CIDR treatments. Beginning on day 1, heifers on the
MGA treatment were fed to consume 0.5 mg
daily of MGA for 7 days. On day 7, the last
day of MGA feeding, the MGA heifers received an injection of Lutalyse1 (PGF2α).
Heifers on the CIDR treatment received a
CIDR on day 3; on day 9 the CIDR was removed, and heifers received an injection of
Lutalyse. On day 11, all heifers received an
injection of OvaCyst2 (gonadotrophinreleasing hormone; GnRH), followed by another injection of Lutalyse® 7 days later (day
18). At 48 hours after the final Lutalyse injection, all heifers were time inseminated and
received an injection of OvaCyst. Pregnancy
status was determined 33 days after breeding
by ultrasonography. No difference in pregnancy rate was observed between the CIDR
(46%) and MGA (47%) treatments.

Use of a progestin in synchronization protocols is desirable because it synchronizes the
estrous cycle by extending the luteal phase
and also induces cyclicity in anestrus or prepubertal females. The progestins most commonly used by beef producers are
melengestrol acetate (MGA), given orally, and
the Eazi-Breed CIDR1, a vaginal insert containing progesterone. Gonadotrophin-releasing
hormone (GnRH) is also regularly included in
estrous synchronization to control timing of
follicular waves and ovulation.
The most commonly used synchronization
protocol for beef heifers consists of feeding
MGA for 14 days, followed by heat detection
and breeding 17 to 19 days later. More recently, protocols have been tested that shorten
the time of progestin administration (7 vs. 14
days) and overall time to breeding (11 vs. 33
days). One example is the 7-11 Cosynch,
which is composed of 7 days of MGA feeding,

Introduction
Artificial insemination offers several advantages, including improving genetics, short-
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Lutalyse and Eazi-Breed CIDR are registered trademarks of Pharmacia Animal Health.
OvaCyst is a registered trademark of Phoenix Scientific.
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Eazi-Breed CIDR on day 3. On day 9, the
CIDR was removed and heifers received an
injection of Lutalyse. On day 11, heifers from
both treatment groups received 2 mL (intramuscular) of OvaCyst. On day 18, all heifers
received an injection of Lutalyse. Timed insemination followed 48 hours later, at which
time heifers were injected with OvaCyst.
Pregnancy status was determined by ultrasonography 33 days after insemination.

followed by the Cosynch protocol starting on
day 11 (Figure 1).
We previously have reported acceptable
conception rates from using MGA with the 711 Cosynch protocol. Here, we compare
MGA and the CIDR as progestin sources in
the 7-11 Cosynch protocol.
Experimental Procedures
Three groups of yearling heifers (n=179) from
the Kansas State University Purebred Unit and
the Cow-Calf Unit were used in this study.
Heifers were blocked by weight (and breed for
the purebred heifers) and assigned to one of
two treatments: MGA or CIDR. Heifers in the
MGA treatment (Figure 1) were group-fed 0.5
mg/heifer daily of MGA (Pharmacia Animal
Health, Kalamazoo, MI) in a grain sorghum
carrier, beginning on day 1. On the last day of
MGA feeding (day 7), heifers were injected
with Lutalyse (5 mL intramuscular). Heifers
in the CIDR treatment (Figure 1) received an

Results and Discussion
Overall, 84 of 179 (47%) heifers were
pregnant. There were no treatment differences
between MGA and CIDR in pregnancy rate;
42 of 89 (47%) for MGA and 42 of 90 (46%)
for CIDR. These pregnancy rates were as
much as 15 to 20% lower than in previous trials using the 7-11 Cosynch timed artificial insemination treatment with MGA. In this direct comparison of MGA and CIDR, however,
there was no advantage of using a CIDR in
place of MGA.
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Figure 1. The 7-11 Cosynch protocols using either melengestrol acetate (MGA) or a
vaginal insert containing progesterone CIDR as the progestin source. Prostaglandin F2α
(PGF2α) was provided as Lutalyse (5 mL, intramuscular). OvaCyst (2 mL, intramuscular) served
as the source of gonadotrophin-releasing hormone (GnRH).
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